Vitiligo
What is it? Vitiligo is a chronic autoimmune skin condition that causes the loss of pigment-producing cells (melanocytes), resulting in white patches of skin. These patches can occur anywhere on the body but are often most noticeable on the face, hands, and other exposed areas. Vitiligo is not contagious or physically harmful, but it can have a significant impact on self-esteem, confidence, and quality of life. Nonsegmental vitiligo is the most common form and may gradually progress over time.
Current available trials:
- Children 2 to under 12 years of age
- Diagnosed with nonsegmental vitiligo
- Evaluating Opzelura® (ruxolitinib cream)
- Study medication applied twice daily to vitiligo-affected areas
- Includes regular assessments of repigmentation, quality of life, and treatment safety
- Study participation lasts approximately 60 weeks